No reviews yet. Be the first to rate Tatiana!
Entenda por que revistas rejeitaram o estudo piloto da polilaminina da UFRJ, erros admitidos e próximos passos com Anvisa e Cristália para tratar lesões medulares.
Explore UFRJ professor Tatiana Sampaio's polilaminina, approved by Anvisa for Phase 1 trials, promising axon regeneration for paraplegia patients in Brazil.
Photo by Hải Mai on Unsplash
Photo by Rachid Wahib on Unsplash
Photo by Kazuo ota on Unsplash
Photo by Marco Antonio Casique Reyes on Unsplash
Photo by David Trinks on Unsplash
Photo by Ling App on Unsplash
Photo by Hermes Rivera on Unsplash
See Research & Publication News in Your CountrySee more Research & Publication News Articles
Have a story or a research paper to share? Become a contributor and publish your work on AcademicJobs.com.
Submit your Research - Make it Global News